Follow CAP on Social Media

Listen to the CAP Podcast

As Infections Rise in Countries Previously Vaccinated With Chinese Jabs, Doubts Persist About Vaccine Efficacy

A medical personel injects the first dose of the Chinese Covid-19 vaccine produced by Sinopharm at the Seychelles Hospital in Victoria, on January 10, 2021. Rassin VANNIER / AFP

The effectiveness of Chinese-made vaccines is emerging as an enduring narrative in the U.S. media due in part to resurgent infection rates in countries that have relied heavily on Sinopharm and Sinovac jabs.

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Africa Project?

Independent

The CAP is passionately independent, non-partisan and does not advocate for any country, company or culture.

News

A carefully curated selection of the day’s most important China-Africa stories. Updated 24 hours a day by human editors. No bots, no algorithms.

Analysis

Diverse, often unconventional insights from scholars, analysts, journalist and a variety of stakeholders in the China-Africa discourse.

Networking

A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.